Dr. Michael Farkouh is professor and vice chair of research in the Department of Medicine at the University of Toronto, and the Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, and director of the Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research.
He is an honors graduate of the Schulich School of Medicine at University of Western Ontario in London, Ontario, Canada. Dr. Farkouh completed his internal medicine and cardiology training at the Mayo Clinic and the Icahn School of Medicine at Mount Sinai New York, respectively, and holds an M.Sc. in clinical epidemiology from McMaster University.
Prior to his current appointments, Dr. Farkouh served as the founding director of the Mount Sinai Cardiovascular Clinical Trials Unit in New York City. He has published over 200 papers largely on acute coronary syndromes and cardio–vascular prevention. He has mentored numerous international residents and fellows and is active in teaching clinical research methodology.
Dr. Farkouh is internationally known for his work on the management of acute coronary syndromes in the emergency room. He has a special interest and expertise in the field of cardiovascular disease in diabetic patients. He directs numerous clinical trials on questions related to diabetes and heart disease including the U.S. National Institutes of Health–sponsored FREEDOM and TAILOR–PCI trials. He chairs the committee on diabetes and heart disease at the Banting and Best Centre and at the University of Toronto and is the founder of the Worldwide Network for Innovation in Clinical Research, an international trials consortium of 10 large academic institutions. Dr. Farkouh has received the Gold Medal from John Paul II Hospital in Krakow, was elected “Teacher of the Year” at the Mayo Clinic and was awarded the Jan J. Kellermann Memorial Award from the International Academy of Cardiology in 2015.